Company / Debt per Share
Pacira BioSciences, Inc. Debt per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Debt per Share
$8.05
FY2025
5-year range
$8.05 / $15.41
FY2021-FY2025
Trend
-36.4%
vs FY2024
Sector context
#28 of 82
Health Care
What the data says
At $8.05, Pacira BioSciences, Inc.'s debt per share ranks #55 of 82 in the Health Care sector. Debt per Share has fluctuated over the past 5 years, ranging from $2.95 in FY2016 to $15.41 in FY2022.
Based on SEC 10-K filings.
8.05 in FY2025 with a 3-year CAGR of -19.5%.
Improved from $11.38 to $8.05 over the past 2 years.
Health Care sector context is included.
Debt per Share over time
Growth rates
- 3-Year CAGR
- -19.5%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#55 of 82 in Health CareTop 66% of 82This company $8.05 Sector average $126.59
▼
-93.6% below sector average
Key checks
Key Insights
- In FY2025, debt per share decreased 36.4% year-over-year.
- Ranks #28 out of 82 companies in the Health Care sector.
- Peak debt per share was recorded in FY2022.
- Lowest debt per share in the period was in FY2016.
Company context
Key Data Points
- High Piotroski F-Score: 8/9 (strong financial health signals)
- Negative profit margin: -14.8%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Debt per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $8.05 | -36.4% |
| FY2024 | $12.66 | +11.3% |
| FY2023 | $11.38 | -26.2% |
| FY2022 | $15.41 | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | $2.95 | +2.5% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026